Weed (BUDZ) Other Non-Current Assets (2010 - 2012)

Weed's (BUDZ) quarterly Other Non-Current Assets came in at $111500.0 in Q1 2012, up 913.64% quarter-over-quarter from $11000.0 in Q4 2011.

Weed (BUDZ) Other Non-Current Assets (2010 - 2012) Analysis & Trends

Weed's Other Non-Current Assets history runs 3 years deep, the most recent figure standing at $111500.0 for Q1 2012.

  • On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $111500.0 in Q1 2012; TTM through Mar 2012 was $111500.0, a N/A change from a year earlier, with the FY2011 full-year figure at $11000.0, changed 0.0% from the prior year.
  • Other Non-Current Assets advanced to $111500.0 in Q1 2012 per BUDZ's latest filing, from $11000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $111500.0 in Q1 2012 and bottomed at $11000.0 in Q4 2010.
  • The 3-year median for Other Non-Current Assets is $108660.0 (2011), against an average of $70164.0.
  • Biggest YoY gain for Other Non-Current Assets was 0.0% in 2011; the steepest drop was 0.0% in 2011.
  • Year by year, Other Non-Current Assets stood at $11000.0 in 2010, then changed by 0.0% to $11000.0 in 2011, then soared by 913.64% to $111500.0 in 2012.
  • Per Business Quant, the three latest BUDZ Other Non-Current Assets figures stand at $111500.0 (Q1 2012), $11000.0 (Q4 2011), and $108660.0 (Q3 2011).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Weed 3.72 Mn 3.72 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2012 111,500.00
Dec 31, 2011 11,000.00
Sep 30, 2011 108,660.00
Jun 30, 2011 108,660.00
Dec 31, 2010 11,000.00